We are live on ! Find out more
TI

Trexquant Investment Portfolio holdings

AUM $13.9B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-5.04%
1 Year Est. Return
+31.98%
3 Year Est. Return
+90.18%
5 Year Est. Return
+73.02%
10 Year Est. Return
+326.84%
AUM
$2.13B
AUM Growth
+$510M
Cap. Flow
+$599M
Cap. Flow %
28.11%
Top 10 Hldgs %
9.95%
Holding
1,881
New
630
Increased
409
Reduced
256
Closed
586

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$26.4M
2
JPM icon
JPMorgan Chase
JPM
+$25.9M
3
AMD icon
Advanced Micro Devices
AMD
+$22.6M
4
ADI icon
Analog Devices
ADI
+$20.1M
5
TSLA icon
Tesla
TSLA
+$17.8M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$20M
2
C icon
Citigroup
C
+$19.9M
3
UBER icon
Uber
UBER
+$17.1M
4
TXN icon
Texas Instruments
TXN
+$17M
5
CMI icon
Cummins
CMI
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Consumer Discretionary 14.89%
3 Healthcare 14.54%
4 Financials 10.84%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLT
1326
DELISTED
Applied Therapeutics
APLT
-11,091
Closed -$99K
APOG icon
1327
Apogee Enterprises
APOG
$873M
-9,187
Closed -$442K
APTV icon
1328
Aptiv
APTV
$12.6B
-1,244
Closed -$205K
AQN icon
1329
Algonquin Power & Utilities
AQN
$4.68B
-32,531
Closed -$470K
ARCT icon
1330
Arcturus Therapeutics
ARCT
$163M
-5,939
Closed -$220K
ARGX icon
1331
argenx
ARGX
$54.6B
-1,058
Closed -$371K
ARKF icon
1332
ARK Blockchain & Fintech Innovation ETF
ARKF
$744M
-51,423
Closed -$2.1M
ARKG icon
1333
ARK Genomic Revolution ETF
ARKG
$1.54B
-29,507
Closed -$1.81M
ARKK icon
1334
ARK Innovation ETF
ARKK
$5.74B
-29,058
Closed -$2.75M
ARKQ icon
1335
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.87B
-10,429
Closed -$803K
ARKW icon
1336
ARK Web x.0 ETF
ARKW
$1.64B
-21,045
Closed -$2.5M
AROC icon
1337
Archrock
AROC
$6.19B
-57,156
Closed -$428K
ARW icon
1338
Arrow Electronics
ARW
$10.8B
-9,059
Closed -$1.22M
ASH icon
1339
Ashland
ASH
$3.11B
-4,148
Closed -$447K
ASIX icon
1340
AdvanSix
ASIX
$551M
-9,492
Closed -$448K
ATHM icon
1341
Autohome
ATHM
$2.65B
-32,361
Closed -$954K
AUPH icon
1342
Aurinia Pharmaceuticals
AUPH
$1.92B
-21,210
Closed -$485K
AUTL
1343
Autolus Therapeutics
AUTL
$386M
-17,956
Closed -$93K
AVDL
1344
DELISTED
Avadel Pharmaceuticals
AVDL
-23,500
Closed -$190K
AVXL icon
1345
Anavex Life Sciences
AVXL
$238M
-13,601
Closed -$236K
AXON
1346
Axon Enterprise
AXON
$44.1B
-12,034
Closed -$1.89M
AXS icon
1347
AXIS Capital
AXS
$8.79B
-16,933
Closed -$922K
AXSM icon
1348
Axsome Therapeutics
AXSM
$12.1B
-8,508
Closed -$321K
AYI icon
1349
Acuity Brands
AYI
$10.3B
-6,584
Closed -$1.39M
AZZ icon
1350
AZZ Inc
AZZ
$4.41B
-7,629
Closed -$422K

Similar funds

Trexquant Investment's Q1 2022 Portfolio in Review

As of Q1 2022, Trexquant Investment held 1,881 positions worth $2.13B, up 32% from $1.62B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Trexquant Investment deployed $599M of net new capital in Q1 2022, opening 630 new positions and adding to 409 existing holdings. Its largest new stake was JPMorgan Chase: 175,235 shares worth $23.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citigroup, an estimated $19.9M trimmed.

  • Trexquant Investment's largest Q1 2022 buy was JPMorgan Chase: 175,235 shares worth $23.9M.
  • Trexquant Investment added most to Micron Technology in Q1 2022, an estimated $26.4M increase.
  • Trexquant Investment's biggest Q1 2022 reduction was Citigroup, cutting an estimated $19.9M.
  • Trexquant Investment fully exited Chevron in Q1 2022, selling an estimated $20M.
  • Trexquant Investment's ten largest holdings make up 9.9% of its $2.13B portfolio in Q1 2022.
  • Trexquant Investment opened 630 new positions and closed 586 in Q1 2022.
  • Trexquant Investment's portfolio value rose 32% quarter-over-quarter to $2.13B.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.